MEI Pharma (MEIP) News Today → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free MEIP Stock Alerts $2.86 -0.04 (-1.38%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 1:20 AM | americanbankingnews.comMEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.comMay 23, 2024 | americanbankingnews.comMEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.comMay 22, 2024 | money.usnews.comMEI Pharma IncMay 14, 2024 | businesswire.comGlancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)May 10, 2024 | investorplace.comMEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024May 9, 2024 | businesswire.comMEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational HighlightsApril 18, 2024 | insidermonkey.com5 Cheap Penny Stocks to Buy According to AnalystsApril 11, 2024 | msn.comMEI Pharma shelves plans for a second return of capitalApril 11, 2024 | businesswire.comMEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344April 11, 2024 | businesswire.comMEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer PatientsApril 10, 2024 | businesswire.comMEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology ForumMarch 26, 2024 | finance.yahoo.comMEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid LeukemiaMarch 20, 2024 | stocknews.com3 Pharma Stocks Outperforming the CompetitionMarch 3, 2024 | investing.comMEI Pharma Inc (MEIP)February 29, 2024 | seekingalpha.comMEIP MEI Pharma, Inc.February 15, 2024 | businesswire.comGlancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)February 15, 2024 | businesswire.comGlancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)February 13, 2024 | finance.yahoo.comMEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational HighlightsFebruary 13, 2024 | finance.yahoo.comMEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue EstimatesFebruary 13, 2024 | businesswire.comMEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational HighlightsFebruary 8, 2024 | wsj.comMEI Pharma Inc.February 8, 2024 | finance.yahoo.comIs MEI Pharma (MEIP) Attractively Priced?January 18, 2024 | forbes.comAcceleron PharmaJanuary 16, 2024 | finance.yahoo.comMEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024December 27, 2023 | benzinga.comMEI Pharma Stock (NASDAQ:MEIP), Short Interest ReportDecember 27, 2023 | benzinga.comMEI Pharma Stock (NASDAQ:MEIP) Dividends: History, Yield and DatesDecember 11, 2023 | finance.yahoo.comMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023November 16, 2023 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)November 14, 2023 | morningstar.comMEI Pharma Inc MEIPNovember 9, 2023 | finance.yahoo.comMEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational HighlightsNovember 8, 2023 | finance.yahoo.comMEI Pharma to Present at the Stifel 2023 Healthcare ConferenceNovember 6, 2023 | finance.yahoo.comMEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common StockNovember 2, 2023 | finance.yahoo.comMEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023November 1, 2023 | finance.yahoo.comMEI Pharma Enters into Agreement with Anson Funds and Cable Car CapitalOctober 17, 2023 | finance.yahoo.comMEI Pharma Recommends Stockholders Not to ConsentOctober 17, 2023 | finance.yahoo.comAstraZeneca's (AZN) Tagrisso Combo Gets FDA's Priority ReviewOctober 17, 2023 | finance.yahoo.comEditas (EDIT) Gets FDA's RMAT Tag for Gene Therapy to Treat SCDOctober 16, 2023 | finance.yahoo.comCatalyst (CPRX) Seeks to Increase Maximum Daily Dose for FirdapseOctober 2, 2023 | finance.yahoo.comMEI Pharma Adopts Limited-Duration Stockholder Rights PlanSeptember 29, 2023 | finance.yahoo.comAll You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong BuySeptember 28, 2023 | stockhouse.comMEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic ActionsSeptember 28, 2023 | finance.yahoo.comMEI Pharma Issues Statement Regarding Anson and Cable Car’s Opportunistic ActionsSeptember 27, 2023 | finance.yahoo.comMEI Pharma, Inc. (NASDAQ:MEIP) Q4 2023 Earnings Call TranscriptSeptember 27, 2023 | finance.yahoo.comQ4 2023 MEI Pharma Inc Earnings CallSeptember 26, 2023 | finance.yahoo.comAnson And Cable Car Send Letter to MEI Pharma StockholdersSeptember 26, 2023 | finance.yahoo.comMEI Pharma Reports Fiscal Year 2023 Results and Operational HighlightsSeptember 26, 2023 | finance.yahoo.comAnson Funds Management LP Acquires Shares in MEI Pharma IncSeptember 25, 2023 | benzinga.comEarnings Outlook For MEI PharmaSeptember 23, 2023 | finance.yahoo.comAnson Funds Management LP Acquires Additional Shares in MEI Pharma IncSeptember 21, 2023 | finance.yahoo.comMEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023 Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… MEIP Media Mentions By Week MEIP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEIP News Sentiment▼0.690.78▲Average Medical News Sentiment MEIP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEIP Articles This Week▼31▲MEIP Articles Average Week Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lumos Pharma News Forte Biosciences News Indaptus Therapeutics News Aptorum Group News Cocrystal Pharma News Synlogic News BioVie News Sol-Gel Technologies News CytoMed Therapeutics News NeuroBo Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MEIP) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
